Search This Blog

Thursday, December 14, 2023

bluebird bio gains on deal with commercial payer

 

Gene therapy maker bluebird bio (BLUE) gains after securing an agreement with a large payer organization

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)